CollaborationGenmab and argenx combine antibody know-howLatest NewsGenmab and argenx have entered a multiyear collaboration bringing together capabilities to jointly discover, develop and commercialise antibody therapies. Read more 17 April 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/argenx.jpg 470 670 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-04-17 14:39:302024-04-11 08:08:35Genmab and argenx combine antibody know-how